Yoseph Bornstein Sells 15,375 Shares of Microbot Medical Inc (MBOT) Stock

Microbot Medical Inc (NASDAQ:MBOT) Director Yoseph Bornstein sold 15,375 shares of the stock in a transaction dated Wednesday, December 6th. The shares were sold at an average price of $1.05, for a total transaction of $16,143.75. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

Yoseph Bornstein also recently made the following trade(s):

  • On Tuesday, November 21st, Yoseph Bornstein sold 45,000 shares of Microbot Medical stock. The shares were sold at an average price of $1.21, for a total transaction of $54,450.00.
  • On Tuesday, November 28th, Yoseph Bornstein sold 45,000 shares of Microbot Medical stock. The shares were sold at an average price of $1.07, for a total transaction of $48,150.00.
  • On Tuesday, October 24th, Yoseph Bornstein sold 50,000 shares of Microbot Medical stock. The shares were sold at an average price of $1.14, for a total transaction of $57,000.00.
  • On Tuesday, October 17th, Yoseph Bornstein sold 50,000 shares of Microbot Medical stock. The shares were sold at an average price of $1.16, for a total transaction of $58,000.00.
  • On Tuesday, October 10th, Yoseph Bornstein sold 50,000 shares of Microbot Medical stock. The shares were sold at an average price of $1.38, for a total transaction of $69,000.00.
  • On Thursday, October 5th, Yoseph Bornstein sold 22,000 shares of Microbot Medical stock. The shares were sold at an average price of $1.49, for a total transaction of $32,780.00.
  • On Wednesday, October 4th, Yoseph Bornstein sold 53,000 shares of Microbot Medical stock. The shares were sold at an average price of $1.20, for a total transaction of $63,600.00.
  • On Tuesday, September 26th, Yoseph Bornstein sold 50,000 shares of Microbot Medical stock. The shares were sold at an average price of $1.24, for a total transaction of $62,000.00.
  • On Tuesday, September 19th, Yoseph Bornstein sold 50,000 shares of Microbot Medical stock. The stock was sold at an average price of $1.18, for a total transaction of $59,000.00.
  • On Tuesday, September 12th, Yoseph Bornstein sold 20,000 shares of Microbot Medical stock. The stock was sold at an average price of $1.12, for a total transaction of $22,400.00.

Microbot Medical Inc (NASDAQ:MBOT) traded up $0.02 during trading on Thursday, reaching $1.07. 355,595 shares of the company traded hands, compared to its average volume of 881,904. Microbot Medical Inc has a 52-week low of $1.00 and a 52-week high of $9.94.

An institutional investor recently raised its position in Microbot Medical stock. Vanguard Group Inc. increased its position in shares of Microbot Medical Inc (NASDAQ:MBOT) by 252.2% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 159,992 shares of the biotechnology company’s stock after purchasing an additional 114,561 shares during the period. Vanguard Group Inc. owned 0.43% of Microbot Medical worth $228,000 at the end of the most recent quarter. 4.72% of the stock is owned by institutional investors and hedge funds.

ILLEGAL ACTIVITY WARNING: This report was first posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this report on another domain, it was copied illegally and reposted in violation of U.S. and international trademark and copyright laws. The legal version of this report can be accessed at https://www.dispatchtribunal.com/2017/12/07/yoseph-bornstein-sells-15375-shares-of-microbot-medical-inc-mbot-stock.html.

Microbot Medical Company Profile

Microbot Medical Inc, formerly StemCells, Inc, is a medical device company. The Company specializes in the researching, designing, developing and commercializing transformational micro-robotic medical technologies leveraging the artificial and natural lumens within the human body. It is engaged in developing its two product candidates: the Self Cleaning Shunt (SCS) for the treatment of hydrocephalus and normal pressure hydrocephalus (NPH), and TipCAT, a self-propelling, semi-disposable endoscope that the Company is developing for use in colonoscopy procedures.

Insider Buying and Selling by Quarter for Microbot Medical (NASDAQ:MBOT)

Receive News & Ratings for Microbot Medical Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microbot Medical Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply